The earnings call highlighted strong performance in the U.S. market, significant EBITDA and gross margin improvements, and robust growth in non-tonic products. However, challenges remain in the UK and European markets, with revenue declines and on-trade channel difficulties noted. Despite these challenges, the company is optimistic about future growth opportunities.
Company Guidance
During the Fevertree Q2 2024 earnings call, the company provided guidance indicating strong financial performance despite challenging market conditions. The executives highlighted an impressive 80% growth in EBITDA and a 520 basis point improvement in gross margin during the first half, with a commitment to achieve 600 basis points for the full year. Revenue growth was reported at 2% on a constant currency basis, with the U.S. market showing double-digit growth and outpacing the total mixer category by 10%. In the U.K., Fevertree maintained its position as the number one brand by value, although it faced challenges in the on-trade sector due to poor weather. The European market saw a 10% decline at constant currency, impacted by weather and order phasing, but underlying brand revenue increased by 1% year-on-year. The Rest of the World region experienced a 56% revenue increase, driven by strong performance in Australia and Canada. Looking ahead, Fevertree anticipates revenue growth acceleration and continued margin recovery, with expectations to deliver a further 200 basis point gross margin improvement in 2025, despite ongoing macroeconomic challenges.
Significant EBITDA Growth
Fevertree delivered almost 80% EBITDA growth, indicating strong margin recovery.
U.S. Market Performance
The brand delivered double-digit growth at constant currency in the U.S., outpacing the total mix of category by about 10%.
Gross Margin Improvement
Improved gross margin by 520 basis points year-on-year during H1, with an expectation of 600 basis points improvement across the full year.
Rest of the World Growth
Delivered a 56% increase in revenue year-on-year in the Rest of the World region, with strong performance in Canada and Australia.
Non-Tonic Product Growth
Non-tonic products have grown by 24% CAGR over the last 6 years, now making up 40% of sales.
---
Fevertree Drinks (FQVTF) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
FQVTF Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Sep 12, 2024
$10.84
$10.08
-7.01%
Mar 26, 2024
$13.60
$15.33
+12.72%
Sep 12, 2023
$16.38
$16.42
+0.24%
Mar 22, 2023
$12.80
$14.24
+11.25%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Fevertree Drinks (FQVTF) report earnings?
Fevertree Drinks (FQVTF) is schdueled to report earning on Apr 01, 2025, TBA Not Confirmed.
What is Fevertree Drinks (FQVTF) earnings time?
Fevertree Drinks (FQVTF) earnings time is at Apr 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.